Configuration
▼
Injection (SubQ)
100% Bioavailability
Golden standard. Pulsatile release. Requires reconstitution.
Oral (Capsule)
~3-5% Bioavailability
Convenient but requires significantly higher dosage.
Molecule Profile
Name
Mod GRF 1-29 (No DAC)
Half-Life
~30 Minutes (Native Pulse)
Mechanism
Binds to GHRH receptors on anterior pituitary. Increases pulsatile release of GH without disrupting negative feedback loops.
Protocol Generated
Wellness Optimization
Total Daily Load
100 mcg
Morning Dose
---
Fasted, 30 min before food
Evening Dose
100 mcg
Pre-bed, 2 hrs post-meal
Clinical Instructions
Reconstitute 2mg vial with 1ml or 2ml BAC water. Inject subcutaneously into abdominal fat pad. Ensure strict fasting window around administration to prevent insulin blunting of GH release.
Cycle Duration
12 Weeks
Washout Period
4 Weeks
Plasma Concentration Model
Efficacy Target Profile